Information for "Endothelial JAK2V617F mutation contributes to thrombosis vasculopathy as well as cardiomyopathy in a murine type of myeloproliferative neoplasm"
From EECH Central
Basic information
Display title | Endothelial JAK2V617F mutation contributes to thrombosis vasculopathy as well as cardiomyopathy in a murine type of myeloproliferative neoplasm |
Default sort key | Endothelial JAK2V617F mutation contributes to thrombosis vasculopathy as well as cardiomyopathy in a murine type of myeloproliferative neoplasm |
Page length (in bytes) | 3,328 |
Page ID | 1305914 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Badgerroast43 (Talk | contribs) |
Date of page creation | 17:24, 26 March 2024 |
Latest editor | Badgerroast43 (Talk | contribs) |
Date of latest edit | 17:24, 26 March 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |